Eric Criscuolo analyst

Currently out of the existing stock ratings of Eric Criscuolo, 18 are a BUY (45%), 21 are a HOLD (52.5%), 1 are a SELL (2.5%).

Eric Criscuolo

Work Performance Price Targets & Ratings Chart

Analyst Eric Criscuolo, has had 95.45% of price targets met with an average potential upside of 14.5%, reached in 215 days on average. Previously, Eric Criscuolo worked at MIZUHO.

Eric Criscuolo has documented 78 price targets and ratings displayed on 11 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on CLVS, Clovis Oncology at 24-Aug-2016.

Wall Street Analyst Eric Criscuolo

Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) on 6/15/2016. The price target of $10 was fulfilled within 1 day with a profit of $0.67 (7.18%), with a performance score of 71.81.

Average potential price target upside

EXAS EXACT Sciences ILMN Illumina MYGN Myriad Genetics TMO Thermo Fisher Scientific CLVS Clovis Oncology FLDM Fluidigm PKI PerkinElmer XON Precigen LAB Standard Biotools PGEN Precigen RVTY Revvity

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 24-Mar-2026

$85

7 months 28 days ago
(24-Mar-2026)

51/51 (100%)

$15.41 (22.14%)

294

Buy Since 10-Apr-2025

$105

$-1714.87 (-94.23%)

$85

10 months 1 days ago
(20-Jan-2026)

3/3 (100%)

$2.65 (2.59%)

89

Buy Since 03-Aug-2021

$105

$-1714.87 (-94.23%)

$68

10 months 16 days ago
(05-Jan-2026)

10/10 (100%)

$3.39 (3.34%)

392

Buy Since 09-Jul-2021

$105

$-1714.87 (-94.23%)

$75

11 months 27 days ago
(25-Nov-2025)

16/16 (100%)

$3.87 (3.83%)

607

Buy Since 06-Nov-2024

$80

11 months 28 days ago
(24-Nov-2025)

2/2 (100%)

$32.58 (68.71%)

229

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?